SCHEMBL7094400

SCHEMBL7094400

CCCC(=O)n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TK1 P04183 2/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PNP P00491 6/20 0.49
BLM P54132 2/20 0.49
USP2 O75604 1/20 0.49
TSHR P16473 1/20 0.49
EDNRA P25101 1/20 0.49
HTR2A P28223 1/20 0.49
RECQL P46063 1/20 0.49
HBB P68871 1/20 0.49
HSD17B10 Q99714 1/20 0.49
XDH P47989 3/20 0.48
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
CYP3A4 P08684 1/20 0.47
NFKB1 P19838 1/20 0.47
VCP P55072 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5347874 0.90 PNP (0.50) TK1MEN1KMT2APNPBLM
SCHEMBL7765224 0.85 TK1 (0.57) TK1MEN1KMT2APNPBLM
SCHEMBL3072984 0.83 PNP (0.51) TK1MEN1KMT2APNPBLM
SCHEMBL27569986 0.82 TK1 (0.46) TK1MEN1KMT2APNPBLM
SCHEMBL218668 0.82 XDH (0.53) TK1MEN1KMT2APNPBLM
SCHEMBL27541246 0.82 XDH (0.58) TK1MEN1KMT2APNPBLM
SCHEMBL27923065 0.82 XDH (0.55) TK1MEN1KMT2APNPBLM
SCHEMBL4446276 0.80 XDH (0.54) TK1MEN1KMT2APNPBLM
SCHEMBL4655346 0.79 PNP (0.62) TK1PNPBLMUSP2TSHR
SCHEMBL704009 0.78 XDH (0.50) TK1MEN1KMT2APNPBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023054391-A1 NUCLEIC ACID STRAND CLEAVING METHOD, NUCLEIC ACID STRAND CLEAVING DEVICE, DOUBLE-STRANDED DNA PRODUCTION METHOD, AND DOUBLE-STRANDED DNA PRODUCTION DEVICE 国立研究開発法人科学技術振興機構 2023-04-06 WO disclosed
EP-1334109-A2 IMPROVED SYNTHESIS OF PURINE LOCKED NUCLEIC ACID ANALOGUES Santaris Pharma A/S (DK) 2003-08-13 EP disclosed
WO-2002028875-A2 IMPROVED SYNTHESIS OF PURINE LOCKED NUCLEIC ACID ANALOGUES CUREON A/S (DK) 2002-04-11 WO disclosed
WO-1997032589-A1 COMBINATIONS FOR TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 1997-09-12 WO disclosed
WO-1997032604-A1 ANTIPROLIFERATIVE COMBINATIONS, CONTAINING RAF-TARGETED OLIGONUCLEOTIDES AND CHEMOTHERAPEUTIC COMPOUNDS NOVARTIS AG (CH) 1997-09-12 WO disclosed